Brain Cancer Trial, Recruiting NCT05775458 Sponsor: IRCCS San Raffaele Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT05775458
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are an adult with a brain lesion that doctors suspect may be a type of brain tumor called GBM (glioblastoma), and you are scheduled for surgery to remove as much of the tumor as possible, followed by radiation therapy and chemotherapy.
  • You are able to understand the study information and give your own consent to take part.

Who may not be able to join:

  • You are under 18 years of age.
  • You have a liver disease or liver condition.
  • You have severe anemia, meaning your hemoglobin (a measure of red blood cells) is very low (confirm with trial site).
  • You are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele
Registry
ClinicalTrials.gov
Start date
1 June 2020
Est. completion
1 November 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Baseline characterization of Glutamate scavengers (Glu-sca) levels in serum; Baseline characterization of Glutamate (Glu) levels in serum; Time changes in Glutamate scavengers (Glu-sca) levels in serum; Time changes in Glutamate (Glu) levels in serum

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov